Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Molica

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Hematology and Cell Therapy|August 24, 1999
Is it time for a reassessment of prognostic features in B-cell chronic lymphocytic leukemia?S Molica
European Journal of Haematology|February 1, 1992
Role of interferon alpha-2b, chlorambucil and prednisone in the treatment of chronic lymphocytic leukemiaS Molica
Haematologica|January 1, 1990
Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of diseaseS Molica, A Alberti
Cancer|December 1, 1987
Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemiaS Molica, A Alberti
Haematologica|March 1, 1990
Analysis of factors associated with short-term survival in chronic myelomonocytic leukemiaS Molica, P Iannaccaro
Haematologica|September 1, 1989
Second neoplasms in chronic lymphocytic leukemia: analysis of incidence as a function of the length of follow-upS Molica, A Alberti
Haematologica|January 9, 2001
What is changing in the natural history of chronic lymphocytic leukemia?S Molica, D Levato
Tumori|December 31, 1986
Prognostic value of "total tumor mass score" (TTM): a retrospective analysis of 130 patients with chronic lymphocytic leukemiaS Molica, A Alberti
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
CD10 expression in B-chronic lymphocytic leukaemiaS Molica, A Dattilo
European Journal of Haematology|July 1, 1988
Investigation of nuclear clefts as a prognostic parameter in chronic lymphocytic leukemiaS Molica, A Alberti
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Hematology and Cell Therapy|August 24, 1999
Is it time for a reassessment of prognostic features in B-cell chronic lymphocytic leukemia?S Molica
European Journal of Haematology|February 1, 1992
Role of interferon alpha-2b, chlorambucil and prednisone in the treatment of chronic lymphocytic leukemiaS Molica
Haematologica|January 1, 1990
Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of diseaseS Molica, A Alberti
Cancer|December 1, 1987
Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemiaS Molica, A Alberti
Haematologica|March 1, 1990
Analysis of factors associated with short-term survival in chronic myelomonocytic leukemiaS Molica, P Iannaccaro
Haematologica|September 1, 1989
Second neoplasms in chronic lymphocytic leukemia: analysis of incidence as a function of the length of follow-upS Molica, A Alberti
Haematologica|January 9, 2001
What is changing in the natural history of chronic lymphocytic leukemia?S Molica, D Levato
Tumori|December 31, 1986
Prognostic value of "total tumor mass score" (TTM): a retrospective analysis of 130 patients with chronic lymphocytic leukemiaS Molica, A Alberti
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
CD10 expression in B-chronic lymphocytic leukaemiaS Molica, A Dattilo
European Journal of Haematology|July 1, 1988
Investigation of nuclear clefts as a prognostic parameter in chronic lymphocytic leukemiaS Molica, A Alberti
Pageof 9